Pharmaceutical Executive-01-01-2014

Pharmaceutical Executive

For Russia—Tough Love

January 21, 2014

From the Editor

0

0

Pharm Exec begins its 34th year with a feature on Russia's ambitious plans to build a homegrown biopharma business. Back in 1980, the biotech industry did not exst. Drugs were still classified as chemicals, developed from the random screening of many thoughts.

Biosimilars or Bust

January 21, 2014

Column

0

0

Where are the biosimilars to help cut costs as the first wave of biologics, or complex, small molecule respiratory drugs, for example, go off patent? They've arrived in Europe, but the U.S. lags...

Russia's Bet on Biopharma

January 21, 2014

Features

0

0

Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney.

The 7 Habits of Highly Effective Competitors

January 01, 2014

Features

0

0

Lessons to win in a shifting market dynamic